首页> 外文期刊>International immunology. >Fibronectin-binding protein I of Streptococcus pyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen-presenting cells.
【24h】

Fibronectin-binding protein I of Streptococcus pyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen-presenting cells.

机译:化脓性链球菌的纤连蛋白结合蛋白I促进了鼠B淋巴细胞的T细胞非依赖性增殖,并增强了MHC II类分子在抗原呈递细胞上的表达。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have previously shown that fibronectin-binding protein I (SfbI) of Streptococcus pyogenes can act as an adjuvant for mucosal-delivered antigens (Medina, E., Talay, S. R., Chhatwal, G. S. and Guzman, C. A. 1998. Eur. J. Immunol. 28:1069). To characterize the underlying mechanism of the adjuvancity, we investigated the in vitro stimulating activity of SfbI. The SfbI protein promoted a dose-dependent proliferation of mouse spleen cells. Studies performed using cellular subpopulations showed that proliferation involved B cells and was T cell- and macrophage-independent. SfbI also induced lg production by B cells in a T cell-independent manner. The kinetics of lg isotype accumulation in supernatant fluids and the analysis of Ig-secreting cells suggested that SfbI stimulates B cells expressing different Ig isotypes rather than promoting the isotype switching of single subpopulations. Experiments performed with recombinant proteins encompassing different functional domains of SfbI showed that the fibronectin-binding repeats were responsible for B cell activation. The sera from mice immunized by the intranasal route with SfbI did not react with either double-stranded DNA, cardiolipin or collagen. Interestingly, stimulation with Sfbl also resulted in the up-regulation of MHC class 11 molecules expression by B cells and macrophages. The elucidation of the underlying molecular events to the immunomodulatory effect exerted by SfbI will facilitate the exploitation of the potential of this molecule for the generation of mucosal vaccines.
机译:我们以前已经证明化脓性链球菌的纤连蛋白结合蛋白I(SfbI)可以作为粘膜递送抗原的佐剂(Medina,E.,Talay,SR,Chhatwal,GS和Guzman,CA 1998. Eur。J. Immunol 28:1069)。为了表征佐剂的潜在机制,我们研究了SfbI的体外刺激活性。 SfbI蛋白促进了小鼠脾细胞的剂量依赖性增殖。使用细胞亚群进行的研究表明,增殖涉及B细胞,且与T细胞和巨噬细胞无关。 SfbI还以不依赖T细胞的方式诱导B细胞产生IgG。 lg同种型在上清液中积累的动力学以及对Ig分泌细胞的分析表明,SfbI刺激表达不同Ig同种型的B细胞,而不是促进单个亚群的同种型转换。用包含SfbI不同功能域的重组蛋白进行的实验表明,纤连蛋白结合重复序列是B细胞活化的原因。经鼻内途径用SfbI免疫的小鼠血清与双链DNA,心磷脂或胶原均不反应。有趣的是,用Sfb1刺激还导致B细胞和巨噬细胞对MHC 11类分子表达的上调。对SfbI发挥的免疫调节作用的潜在分子事件的阐明将促进该分子在粘膜疫苗生产中的潜力的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号